VBRI – Vaccine Board Research Institute

The Vaccine Board Research Institute (VBRI) is an elite vaccine production and research organization located in Hyderabad, South India. As part of Indian Immunological Limited (IIL) and operating under the Ministry of Health, Government of India, VBRI plays an important role in the nation’s immunization efforts, producing a wide range of life-saving vaccines.

State-of-the-Art Vaccine Facility

In 2017-2018, for the construction of VBRI’s innovative production facility Chempharm was entrusted, as pioneer in delivering high-quality turnkey solutions for cleanroom and pharmaceutical environments. The facility was designed and built to meet the stringent standards of ISO Class 7 and ISO Class 8 cleanrooms, assuring the particle free sterile environment which is crucial for the process of Vaccine research and production process.

Chempharm’s Role and Offerings
Chempharm provided a complete range of services and infrastructure to develop this premier vaccine facility, including:

Civil Works: The team of Chempharm ensured that the structural design and construction of the facility was optimized for large-scale vaccine production and research while ensuring regulatory standards.

Cleanroom Solutions: Installation of ISO Class 7 and ISO Class 8 cleanrooms, was completed while ensuring an extremely clean and sterile environment which is critical for vaccine manufacturing.

HVAC System: Specialized Heating, Ventilation, and Air Conditioning systems customized to maintain precise environmental controls crucial for controlled and temperature-sensitive processes.

Electrical System: Comprehensive electrical infrastructure was designed, ensuring reliable power distribution throughout the plant for optimized operations.

Laboratories and Containment Equipment: Fully equipped, top-of-the-line laboratories were designed and built for vaccine research and testing, along with advanced containment solutions to safely handle sensitive and biohazardous materials.

Commitment to Vaccine Production
VBRI’s facility is an essential part of India’s national vaccine mission, producing a large number of vaccines to support public health initiatives. From developing childhood immunization vaccines to other essential preventive healthcare solutions, VBRI’s innovative infrastructure enables the production of high-quality vaccines to meet both domestic and international demand.

A Trusted Partnership
This collaboration with VBRI, is a reflection of Chempharm’s expertise in delivering fully integrated, compliant, and advanced facilities for critical sectors like vaccine production. This project is an example of Chempharm’s commitment to supporting public health by providing the essential infrastructure needed for large-scale vaccine research and manufacturing.

Scroll to Top